Market Overview

Infinera Offers A Healthy Structural Sales Growth, Margin Expansion Story


Nomura analyst Jeffrey Kvaal believes Infinera Corp. (NASDAQ: INFN) offered a health structural sales growth. The analyst also expects the company's margin expansion story to help its bottom line in the upcoming years. As a result, the analyst initiated the stock with a rating of Buy with a price target of $17. It meant the stock provided 28.2 percent upside rewards based on Thursday's closing price.

The brokerage said Infinera's PIC chip has driven share gains in a growing optical market. This included the rapidly expanding webscale customers. Kvaal also expects emerging webscale competition and weakness as a key customer mar the current year's story.

However, the analyst commented, "we believe INFN's 1Q reset has de-risked estimates, providing an attractive multiple for an entry point." Accordingly, the revised fiscal year 2016 EPS estimation is $0.85 and for the fiscal year 2017, the analyst project $0.91.

Latest Ratings for INFN

Jun 2020MKM PartnersMaintainsBuy
May 2020Northland Capital MarketsDowngradesOutperformMarket Perform
May 2020JefferiesMaintainsUnderperform

View More Analyst Ratings for INFN
View the Latest Analyst Ratings


Related Articles (INFN)

View Comments and Join the Discussion!

Posted-In: Jeffrey Kvaal NomuraNews Price Target Initiation Analyst Ratings

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at